CADTH Canadian Drug Expert Committee Recommendation: Onabotulinumtoxin A (Botox -- Allergan Inc.) indication: chronic migraine
Corporate Author: | |
---|---|
Format: | eBook |
Language: | English |
Published: |
Ottawa (ON)
CADTH
October 2019, 2019
|
Edition: | Version 1.0 |
Series: | CADTH common drug review
|
Online Access: | |
Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Physical Description: | 1 PDF file (13 pages) |
---|